Regeneron’s drug reduces COVID risk by 81.6% – study

Regeneron Pharmaceuticals Inc. revealed on Monday that a single dose of its drug REGEN-COV reduced the risk of COVID-19 by 81.6% in the phase 3 trial conducted with the United States National Institut…